相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma
Marutpong Detarya et al.
LIFE SCIENCES (2021)
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Chinmayee Sethy et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
Nathakan Klinhom-on et al.
HELIYON (2021)
Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient
Banchob Sripa et al.
HUMAN CELL (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling
Marutpong Detarya et al.
GLYCOBIOLOGY (2020)
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2019)
Clinical presentation, diagnosis and staging of cholangiocarcinoma
Alejandro Forner et al.
LIVER INTERNATIONAL (2019)
FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression
Vidhya Varghese et al.
SCIENTIFIC REPORTS (2019)
Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway
Somsiri Indramanee et al.
SCIENTIFIC REPORTS (2019)
Mouse thymidylate synthase does not show the inactive conformation, observed for the human enzyme
Anna Dowiercial et al.
STRUCTURAL CHEMISTRY (2017)
Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states
Dan Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The molecular mechanisms of chemoresistance in cancers
Hua-Chuan Zheng
ONCOTARGET (2017)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Establishment and characterization of triple drug resistant head and neck squamous cell carcinoma cell lines
Sindhu Valiyaveedan Govindan et al.
MOLECULAR MEDICINE REPORTS (2015)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Dysregulated Expression of FOXM1 Isoforms Drives Progression of Pancreatic Cancer
Xiangyu Kong et al.
CANCER RESEARCH (2013)
Chemotherapy for cholangiocarcinoma: An update
Natalia Ramirez-Merino et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2013)
Cholangiocarcinoma-controversies and challenges
Tushar Patel
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway
Ichiro Nakano et al.
NEURO-ONCOLOGY (2011)
Thiazole antibiotics against breast cancer
Marianna Halasi et al.
CELL CYCLE (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
Uppoor G. Bhat et al.
PLOS ONE (2009)
FoxM1 Is a General Target for Proteasome Inhibitors
Uppoor G. Bhat et al.
PLOS ONE (2009)
Intrahepatic cholangiocardnoma - Rising frequency, improved survival, and determinants of outcome after resection
Itaru Endo et al.
ANNALS OF SURGERY (2008)
5-fluorouracil: Mechanisms of resistance and reversal strategies
Ning Zhang et al.
MOLECULES (2008)
Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1
Senthil K. Radhakrishnan et al.
CANCER RESEARCH (2006)
A proposed clinical test for monitoring fluoropyrimidine therapy - Detection and stability of thymidylate synthase ternary complexes
Jonathan R. Brody et al.
CANCER BIOLOGY & THERAPY (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100)
Banchob Sripa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines
Nisana Tepsiri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
The role of chemotherapy in cholangiocarcinoma
S Thongprasert
ANNALS OF ONCOLOGY (2005)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
GJ Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug
J Phan et al.
BIOCHEMISTRY (2001)
分享论文
